Vivanco, I, Robins, HI, Rohle, D, Campos, C, Grommes, C, Nghiemphu, PL, Kubek, S, Oldrini, B, Chheda, MG, Yannuzzi, N, Tao, H, Zhu, S, Iwanami, A, Kuga, D, Dang, J, Pedraza, A, Brennan, CW, Heguy, A, Liau, LM, Lieberman, F, Yung, WKA, Gilbert, MR, Reardon, DA, Drappatz, J, Wen, PY, Lamborn, KR, Chang, SM, Prados, MD, Fine, HA, Horvath, S, Wu, N, Lassman, AB, DeAngelis, LM, Yong, WH, Kuhn, JG, Mischel, PS
, Mehta, MP, Cloughesy, TF & Mellinghoff, IK 2012, '
Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.',
Cancer Discovery, vol. 2.
https://doi.org/10.1158/2159-8290.CD-11-0284